Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
2.290
-0.030 (-1.29%)
At close: Oct 23, 2026, 4:00 PM EDT
2.250
-0.040 (-1.75%)
After-hours: Oct 23, 2026, 4:10 PM EDT
Kiora Pharmaceuticals Employees
Kiora Pharmaceuticals had 13 employees as of December 31, 2025. The number of employees increased by 1 or 8.33% compared to the previous year. That makes Kiora Pharmaceuticals the 39,691st largest employer in the world and 5,852nd in the United States.
Employees
13
Change (1Y)
1
Growth (1Y)
8.33%
Revenue / Employee
n/a
Profits / Employee
-$845,131
Market Cap
14.57M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 13 | 1 | 8.33% |
| Dec 31, 2024 | 12 | 0 | - |
| Dec 31, 2023 | 12 | 0 | - |
| Dec 31, 2022 | 12 | -2 | -14.29% |
| Dec 31, 2021 | 14 | 0 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 138 |
| Fractyl Health | 100 |
| aTyr Pharma | 60 |
| BioCardia | 21 |
| Radiopharm Theranostics | 14 |
| NewcelX | 12 |
| Psyence Biomedical | 12 |
| Allarity Therapeutics | 8 |
KPRX News
- 2 months ago - Kiora Pharmaceuticals Licenses South Korean Ophthalmic Development and Commercialization Rights for KIO-301 to Chong Kun Dang Pharmaceutical Corporation - Newsfile Corp
- 2 months ago - Kiora Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Newsfile Corp
- 2 months ago - Kiora Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 2 months ago - Kiora Pharmaceuticals Earnings release: Q2 2026 - Filings
- 2 months ago - Kiora Pharmaceuticals Slides: Q2 2026 - Filings
- 3 months ago - Kiora Pharmaceuticals to Participate in Piper Sandler Virtual Ophthalmology Symposium - Newsfile Corp
- 4 months ago - Kiora Pharmaceuticals Reports its Ion Channel Modulator, KIO-300, Suppressed Seizure Activity in Preclinical Epilepsy Model - Newsfile Corp
- 4 months ago - Kiora Pharmaceuticals Slides: Corporate presentation - Filings